Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL) disclosed a repurchase of 27,000 ordinary shares on 24 June 2026 via on-market transactions on the Hong Kong Stock Exchange.

The shares were bought at prices ranging from HKD 0.96 to HKD 0.97, translating to a volume-weighted average price of HKD 0.963 and a total consideration of HKD 26,001 (approximately HKD 0.03 million).

Following the transaction: • Issued shares (excluding treasury) fell to 1,034.01 million, down by 27,000 shares, or 0.00261%. • Treasury shares rose to 7.31 million, while total issued shares remained unchanged at 1,041.33 million.

The buyback was executed under the mandate approved on 5 June 2026, which authorises the company to repurchase up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 249,000 shares, representing 0.02408% of the issued share base on the mandate date.

A moratorium on new share issues or sales of treasury shares is in place until 24 July 2026, in line with Hong Kong listing rules.